المؤلفون: Wyles, D, Weiland, O, Yao, B, Weilert, F, Dufour, JF, Gordon, SC, Stoehr, A, Brown, A, Mauss, S, Zhang, ZZ, Pilot-Matias, T, Rodrigues, L, Mensa, FJ, Poordad, F

المصدر: Journal of hepatology. 70(5):1019-1023

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:140686849

المؤلفون: Terrault, N. ^*, Reddy, K.R., Poordad, F., Curry, M., Schiano, T., Johl, J., Shaikh, O., Dove, L., Shetty, K., Millis, M., Schiff, E., Regenstein, F., Barnes, D., Barin, B., Peters, M., Roland, M., Stock, P.

المصدر: In American Journal of Transplantation May 2014 14(5):1129-1135

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Sulkowski, Mark S., Shiffman, Mitchell L., Afdhal, Nezam H., Reddy, K. Rajender, McCone, Jonathan, Lee, William M., Herrine, Steven K., Harrison, Stephen A., Poordad, F. Fred, Koury, Kenneth, Deng, Weiping, Noviello, Stephanie, Pedicone, Lisa D., Brass, Clifford A., Albrecht, Janice K., McHutchison, John G.

المصدر: In Gastroenterology 2010 139(5):1602-1611

المؤلفون: Zeuzem, S, Foster, G, Wang, S, Asatryan, A, Gane, E, Feld, J, Asselah, T, Bourliere, M, Ruane, P, Wedemeyer, H, Pol, S, Flisiak, R, Poordad, F, Chuang, W, Stedman, C, Flamm, S, Kwo, P, Dore, G, Sepulveda-Arzola, G, Roberts, S, Soto-Malave, R, Kaita, K, Puoti, M, Vierling, J, Tam, E, Vargas, H, Bruck, R, Fuster, F, Paik, S, Felizarta, F, Kort, J, Fu, B, Liu, R, Ng, T, Pilot-Matias, T, Lin, C, Trinh, R, Mensa, F, Zeuzem S., Foster G. R., Wang S., Asatryan A., Gane E., Feld J. J., Asselah T., Bourliere M., Ruane P. J., Wedemeyer H., Pol S., Flisiak R., Poordad F., Chuang W. -L., Stedman C. A., Flamm S., Kwo P., Dore G. J., Sepulveda-Arzola G., Roberts S. K., Soto-Malave R., Kaita K., Puoti M., Vierling J., Tam E., Vargas H. E., Bruck R., Fuster F., Paik S. -W., Felizarta F., Kort J., Fu B., Liu R., Ng T. I., Pilot-Matias T., Lin C. -W., Trinh R., Mensa F. J.

مصطلحات الفهرس: HCV DAA, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/304360
info:eu-repo/semantics/altIdentifier/pmid/29365309
info:eu-repo/semantics/altIdentifier/wos/WOS:000423233400008
volume:378
issue:4
firstpage:354
lastpage:369
numberofpages:16
journal:NEW ENGLAND JOURNAL OF MEDICINE

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Mensa F.J., Felizarta F., Reindollar R.W., Gordon S.C., Pianko S., Fried M.W., Bernstein D.E., Gallant J., Lin C.-W., Lei Y., Ng T.I., Krishnan P., Kopecky-Bromberg S., Kort J., Poordad F., Pol S., Asatryan A., Buti M., Shaw D., Hezode C.

مصطلحات الفهرس: drug safety, drug tolerability, drug treatment failure, female, gastrointestinal infection/si [Side Effect], headache/si [Side Effect], virus infection/si [Side Effect], wound infection/si [Side Effect], asunaprevir/dt [Drug Therapy], boceprevir/cb [Drug Combination], boceprevir/dt [Drug Therapy], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], dasabuvir/cb [Drug Combination], dasabuvir/dt [Drug Therapy], glecaprevir plus pibrentasvir/ae [Adverse Drug Reaction], glecaprevir plus pibrentasvir/ct [Clinical Trial], glecaprevir plus pibrentasvir/dt [Drug Therapy], glecaprevir plus pibrentasvir/po [Oral Drug Administration], hepacivirin inhibitor/cb [Drug Combination], hepacivirin inhibitor/dt [Drug Therapy], ledipasvir/dt [Drug Therapy], ledipasvir plus sofosbuvir/dt [Drug Therapy], nonstructural protein 5A inhibitor/cb [Drug Combination], nonstructural protein 5A inhibitor/dt [Drug Therapy], ombitasvir/dt [Drug Therapy], ombitasvir plus paritaprevir plus ritonavir/cb [Drug Combination], ombitasvir plus paritaprevir plus ritonavir/dt [Drug Therapy], paritaprevir/dt [Drug Therapy], peginterferon/cb [Drug Combination], peginterferon/dt [Drug Therapy], ribavirin/cb [Drug Combination], ribavirin/dt [Drug Therapy], simeprevir/cb [Drug Combination], simeprevir/dt [Drug Therapy], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], telaprevir/dt [Drug Therapy], telaprevir/cb [Drug Combination], Hepatitis C virus genotype 1, Hepatitis C virus genotype 4, Hepatitis C virus genotype 5, Hepatitis C virus genotype 6, human, liver cell carcinoma/si [Side Effect], major clinical study, male, medical history, multicenter study, open study, phase 3 clinical trial, priority journal, randomized controlled trial, relapse, retreatment, sustained virologic response, treatment duration, treatment response, adult, aged, antiviral therapy, article, backache/si [Side Effect], chronic hepatitis C/dt [Drug Therapy], chronopharmacology, clinical evaluation, clinical outcome, combination drug therapy, compensated liver cirrhosis, controlled study, drug efficacy, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37408
Hepatology
Click here for full text options
LibKey Link

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Sievert W., Mollison L., Brau N., Levin J., Hughes E.A., Swenson E.S., Yin P.D., Sepe T., Lee S., Boyer N., Bronowicki J.-P., Jacobson I.M., Boparai N., Poordad F.

مصطلحات الفهرس: asunaprevir, asunaprevir plus beclabuvir plus daclatasvir, beclabuvir, daclatasvir, endogenous compound, interleukin 28B, ribavirin, human, adverse drug reaction, antiviral activity, clinical trial, controlled clinical trial, controlled study, death, diarrhea, drug combination, drug therapy, drug withdrawal, fatigue, female, genetic polymorphism, headache, Hepatitis C virus genotype 1, infection, liver cirrhosis, major clinical study, male, nausea, nonhuman, pharmacokinetics, phase 3 clinical trial, safety, side effect, treatment failure, Conference Abstract

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41154
Click here for full text options
LibKey Link